跳至主要内容
临床试验/NL-OMON53429
NL-OMON53429招募中不适用

GOSAT: The role of Galacto-oligosaccharides (GOS) in the recovery from dysbiosis in patients on long-term atypical antipsychotic treatment - Prebiotics among users of atypical antipsychotics

eids Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • age between 18 - 75 years • who receive atypical antipsychotic medication
  • (>=0.5 defined daily dose [DDD], olanzapine, risperidone, clozapine, quetiapine,
  • and aripiprazol) within the preceding eight weeks • who are overweight or obese
  • (BMI >25 kg/m2)

排除标准

  • pregnancy
  • breastfeeding
  • expected discharge or transfer within 10 weeks
  • contra-indication for prebiotics
  • continuous use of pre-, pro-, or synbiotics (within the preceding 4 weeks)
  • recent (8 week) use or continuous use of antibiotics
  • cow's milk allergy/lactose intolerance

研究者

相似试验